Hirata Aya, Okamura Tomonori, Sugiyama Daisuke, Kuwabara Kazuyo, Kadota Aya, Fujiyoshi Akira, Miura Katsuyuki, Okuda Nagako, Ohkubo Takayoshi, Okayama Akira, Ueshima Hirotsugu
Department of Preventive Medicine and Public Health, Keio University School of Medicine.
J Atheroscler Thromb. 2016 Jul 1;23(7):800-9. doi: 10.5551/jat.33449. Epub 2016 Feb 26.
There is no community-based cohort study to examine the effect of very high level of high-density lipoprotein cholesterol (HDL-C) on coronary heart disease (CHD) and other cause-specific mortality. Therefore, we investigated the relationship between HDL-C including very high level and cause-specific mortality in a 20-year cohort study of the representative sample of Japanese.
We followed 7,019 individuals from the Japanese general population (2,946 men and 4,073 women). We defined HDL-C levels as follow: low (HDL-C <1.04 mmol/L), reference (1.04-1.55 mmol/L), high (1.56-2.06 mmol/L), very high (≥2.07 mmol/L). The multivariate adjusted hazard ratio (HR) for all-cause or cause-specific mortality was calculated using a Cox proportional hazards model adjusted for other traditional risk factors.
During follow-up, we observed 1,598 deaths. No significant association was observed between HDL-C and all-cause mortality. Serum HDL-C also showed no association with stroke. In contrast, the risk for CHD among high HDL-C was lower than reference, HRs were 0.51 [95% confidence interval (CI): 0.21-1.23] in men, 0.33 (95% CI: 0.11-0.95) in women, and 0.41 (95% CI: 0.21-0.81) when men and women were combined. However, very high HDL-C did not show significant association with CHD and other cause-specific mortality.
HDL-C was not associated with all-cause and stroke mortality. In contrast, high serum HDL-C levels, at least up to 2.06 mmol/L, were protective against CHD, although further high levels were not. However, sample size of cause-specific death in very high HDL-C group was not enough even in this 20-year follow-up of 7,019 Japanese; larger cohort studies should be warranted.
尚无基于社区的队列研究来检验极高水平的高密度脂蛋白胆固醇(HDL-C)对冠心病(CHD)及其他特定病因死亡率的影响。因此,我们在一项针对日本代表性样本的20年队列研究中,调查了包括极高水平在内的HDL-C与特定病因死亡率之间的关系。
我们追踪了来自日本普通人群的7019人(2946名男性和4073名女性)。我们将HDL-C水平定义如下:低(HDL-C<1.04 mmol/L)、参照(1.04 - 1.55 mmol/L)、高(1.56 - 2.06 mmol/L)、极高(≥2.07 mmol/L)。使用针对其他传统风险因素进行调整的Cox比例风险模型计算全因或特定病因死亡率的多变量调整风险比(HR)。
在随访期间,我们观察到1598例死亡。未观察到HDL-C与全因死亡率之间存在显著关联。血清HDL-C与中风也无关联。相比之下,HDL-C水平高的人群中冠心病风险低于参照组,男性的HR为0.51 [95%置信区间(CI):0.21 - 1.23],女性为0.33(95% CI:0.11 - 0.95),男女合并时为0.41(95% CI:0.21 - 0.81)。然而,极高HDL-C与冠心病及其他特定病因死亡率未显示出显著关联。
HDL-C与全因及中风死亡率无关。相比之下,血清HDL-C高水平(至少高达2.06 mmol/L)对冠心病具有保护作用,尽管更高水平并非如此。然而,即使在对7019名日本人进行的这20年随访中,极高HDL-C组特定病因死亡的样本量也不足;需要开展更大规模的队列研究。